Urinary incontinence is characterized by loss of bladder control, which makes a person leak urine by accident. Urinary incontinence is more common in older people, especially women. In January 2022, a research published in the ‘Menopause Journal, reported that postmenopausal women, aged between 45 to 54 years, are more likely to have overactive bladder syndrome and obesity. Stress incontinence, overactive bladder, mixed incontinence, and overflow incontinence are four types of the condition.
Availability of various treatment options is expected to propel growth of the global urinary incontinence treatment drugs market over the forecast period. For instance, in September 2020, U.S-based Transformative Dermatology, added state-of-the-art Emsella, a non-invasive, pain-free treatment option specifically designed to relieve the symptoms of urinary incontinence.
Moreover, approval and launch of new products is also expected to propel growth of the global urinary incontinence treatment drugs market over the forecast period. For instance, in December 2020, The U.S Food and Drug Administration approved vibegron (Gemtesa) for the treatment of adult patients with overactive bladder.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/4400
Covid-19 Impact Analysis
Globally, as of 4:14pm CET, 29 December 2021, there have been 281,808,270 confirmed cases of COVID-19, including 5,411,759 deaths, reported to WHO. As of 28 December 2021, a total of 8,687,201,202 vaccine doses have been administered. Restrictions on hospital services have impacted the specialized investigations and surgical management of patients with urinary incontinence.
Key Takeaways
Major players operating in the global urinary incontinence treatment drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2020, Strides Pharma Global Pte Ltd., a Singapore-based subsidiary of Strides Pharma Science, received U.S Food and Drug Administration approval for generic Oxybutynin Chloride tablets used to treat symptoms of overactive bladder and urinary incontinence.
Competitive Landscape:
Major players operating in the global urinary incontinence treatment drugs market include, Astellas Pharma, Inc., Allergan, Inc., Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.
Reasons to Buy this Urinary Incontinence Treatment Drugs Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Urinary Incontinence Treatment Drugs market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Urinary Incontinence Treatment Drugs market
➡Leading company profiles reveal details of key Urinary Incontinence Treatment Drugs market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Urinary Incontinence Treatment Drugs market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat 30% Off @
https://www.coherentmarketinsights.com/insight/buy-now/4400
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Incontinence Type
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- New Lunches and Approvals
- Pipeline Analysis
- PEST Analysis
- Epidemiology
- Market Dynamics
- Global Urinary Incontinence Treatment Drugs Market – Impact of Coronavirus (Covid-19) Pandemic
- Supply side Analysis
- Demand Side Analysis
- Impact on Healthcare Industry
- Global Urinary Incontinence Treatment Drugs Market, By Incontinence Type, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Urge Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Stress Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Over-flow Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Mixed Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Other Type
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Urinary Incontinence Treatment Drugs Market, By Drug Class, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Anticholinergic/Antispasmodic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Skeletal Muscle Relaxants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Alpha Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Topical Estrogens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Urinary Incontinence Treatment Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacies
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacies
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Urinary Incontinence Treatment Drugs Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Incontinence Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Incontinence Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Latin America
- Market Size and Forecast, By Incontinence Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Asia Pacific
- Market Size and Forecast, By Incontinence Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Incontinence Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Incontinence Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Astellas Pharma, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Allergan, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Johnson & Johnson
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837